VivoSphere
PrivateLast Round
Grant
May 14, 2026
Total Funding Raised
$575,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
VivoSphere is a biotechnology company that develops advanced 3D tissue-engineered models for drug discovery and toxicity testing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VivoSphere Comparables
Compare VivoSphere with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Obatala Sciences | 84% | |
| Altis Biosystems | 83% | |
| BiomimX | 82% |
VivoSphere Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 14, 2026 | ||||
| Grant | May 1, 2025 | ||||
| Grant | Sep 16, 2024 | ||||
| Grant | May 22, 2024 | ||||
| Grant | Aug 17, 2023 |
VivoSphere Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Alabama Launchpad | Grant |
| National Science Foundation | Grant |
| InvestAL | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 14, 2026
Monthly visitors increased 128% MoM.
- Sep 16, 2024
$100K grant received from InvestAL.
VivoSphere Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about VivoSphere's valuation, stock price, and market status.
Is VivoSphere a public or private company?
VivoSphere is a private company.
What is the current stock price of VivoSphere?
VivoSphere is a private company, so its shares have no public market price. Caplight tracks VivoSphere's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is VivoSphere worth (valuation)?
Valuation information for VivoSphere is not publicly available.
Can I buy VivoSphere stock?
VivoSphere shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was VivoSphere's last funding round?
VivoSphere's most recent funding round was Grant on May 14, 2026.
Who are the main investors in VivoSphere?
Key investors in VivoSphere include NIH RADx, Alabama Launchpad, National Science Foundation, InvestAL.
Will VivoSphere IPO soon?
No public IPO plans have been announced for VivoSphere.
How can I track VivoSphere secondary market activity?
Caplight tracks bids, offers, and trades in VivoSphere's shares on secondary markets.